William R. Ringo is Director at FIVE PRIME THERAPEUTICS, INC. (FPRX). They have made 14 open-market trades across 6 companies since 2006, most recently 2023-07-10.
CIK 0001238325
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FPRX | SELL | 2020-11-11 | 2020-11-13 | $22.50 | $3.0M | -6.5% | -11.1% | +0.9% |
| ASMB | SELL · 10b5-1 | 2018-07-02 | 2018-07-03 | $38.50 | $39K | +4.7% | +5.0% | -8.1% |
| ASMB | SELL · 10b5-1 | 2018-06-01 | 2018-06-01 | $42.47 | $42K | +8.1% | -8.7% | -6.8% |
| ASMB | SELL · 10b5-1 | 2018-05-01 | 2018-05-02 | $43.06 | $43K | -6.2% | -3.9% | -1.5% |
| ASMB | SELL · 10b5-1 | 2018-04-02 | 2018-04-02 | $49.32 | $49K | +3.6% | -4.1% | -15.5% |
| ASMB | SELL | 2018-03-01 | 2018-03-02 | $56.37 | $56K | +10.0% | -19.8% | -27.5% |
| ASMB | SELL · 10b5-1 | 2018-02-01 | 2018-02-02 | $46.86 | $47K | +18.6% | +22.4% | -6.3% |
| ASMB | SELL · 10b5-1 | 2018-01-02 | 2018-01-03 | $45.04 | $45K | -0.7% | +1.0% | +3.3% |
| ASMB | SELL · 10b5-1 | 2017-12-01 | 2017-12-04 | $49.37 | $49K | -4.9% | +2.1% | +25.8% |
| FPRX | SELL · 10b5-1 | 2017-11-01 | 2017-11-02 | $45.33 | $27K | -41.9% | -43.1% | -54.4% |
| ASMB | SELL · 10b5-1 | 2017-11-01 | 2017-11-03 | $29.55 | $30K | +9.6% | +48.1% | +51.5% |
| ASMB | SELL · 10b5-1 | 2017-10-16 | 2017-10-17 | $33.70 | $34K | -1.4% | +11.1% | +45.4% |
| FPRX | SELL | 2017-09-29 | 2017-10-03 | $40.26 | $72K | +13.5% | +13.7% | -41.2% |
| FPRX | SELL | 2017-09-28 | 2017-10-02 | $38.00 | $76K | +8.0% | +7.5% | -44.2% |
| SGMO | SELL | 2017-09-20 | 2017-09-22 | $14.37 | $445K | +22.3% | -2.2% | +18.0% |
| ASMB | SELL | 2017-05-12 | 2017-05-16 | $22.00 | $76K | +11.4% | -5.3% | +3.7% |
| DERM | SELL · 10b5-1 | 2017-05-01 | 2017-05-03 | $34.06 | $17K | -5.7% | +9.2% | +9.2% |
| DERM | SELL · 10b5-1 | 2017-04-03 | 2017-04-04 | $34.03 | $17K | -5.7% | +9.2% | +9.2% |
| FPRX | SELL · 10b5-1 | 2017-03-01 | 2017-03-01 | $46.73 | $23K | -9.6% | -20.0% | -37.6% |
| DERM | SELL · 10b5-1 | 2017-03-01 | 2017-03-02 | $35.09 | $18K | -5.7% | +9.2% | +9.2% |
| DERM | SELL · 10b5-1 | 2017-02-15 | 2017-02-16 | $32.00 | $16K | -5.7% | +9.2% | +9.2% |
| FPRX | SELL · 10b5-1 | 2017-02-01 | 2017-02-01 | $46.17 | $23K | -0.7% | -9.0% | -30.5% |
| DERM | SELL · 10b5-1 | 2017-01-04 | 2017-01-04 | $32.00 | $16K | -5.7% | +9.2% | +9.2% |
| FPRX | SELL · 10b5-1 | 2017-01-03 | 2017-01-03 | $51.07 | $26K | -0.8% | -6.5% | -27.3% |
| DERM | SELL · 10b5-1 | 2016-12-16 | 2016-12-16 | $32.00 | $4K | -5.7% | +9.2% | +9.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.